Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Emerging Players The emerging players in the glucagon-like peptide 1 (GLP-1) analogues market include Gmax Biopharm., Sciwind Biosciences Co., Ltd., Teva Pharmaceuticals, Inc., Hikma Pharmaceuticals PLC (Hikma), Viking Therapeutics, Terns Pharmaceuticals, Inc., Altimmune, AVVA Pharmaceuticals Ltd, LEXICARE PHARMA PVT
This is especially important for people on highly restrictive eating plans, older adults, vegetarians, vegans, or those with certain digestive or absorption issues
When your cells dont respond well to insulin, your body ends up storing more of what you eat as fat rather than burning it
Retatrutide remains an investigational compound in Phase 3 clinical trials and is not approved by Health Canada for human or veterinary use
Retatrutide is a triple agonist, targeting the receptors of 3 hormones that can impact appetite, weight, and blood sugar levels, earning it the nicknames the triple-G and the Godzilla of weight loss jabs
US$ 21.83
US$ 22.06
US$ 23.42
US$ 25.83
US$ 25.78
US$ 26.14
